Edwards Lifesciences (EW) Current Deferred Tax Assets (2009 - 2015)

Edwards Lifesciences' Current Deferred Tax Assets history runs 7 years deep, the most recent figure standing at $79.0 million for Q3 2015.

• In Q3 2015, Current Deferred Tax Assets rose 167.8% year-over-year to $79.0 million; the TTM figure through Sep 2015 stood at $79.0 million (up 167.8% YoY), while the FY2014 annual figure was $63.5 million, up 90.12% from the prior year.
• Current Deferred Tax Assets was $79.0 million for Q3 2015 at Edwards Lifesciences, up from $65.2 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $79.0 million in Q3 2015 to a low of $25.3 million in Q3 2011.
• Historically, Current Deferred Tax Assets has averaged $44.9 million across 5 years, with a median of $42.4 million in 2012.
• The sharpest annual moves came in 2012 and 2015: Current Deferred Tax Assets sank 43.57% in 2012, then surged 167.8% in 2015.
• A 5-year view of Current Deferred Tax Assets shows it stood at $43.9 million in 2011, then retreated by 1.14% to $43.4 million in 2012, then slipped by 23.04% to $33.4 million in 2013, then surged by 90.12% to $63.5 million in 2014, then advanced by 24.41% to $79.0 million in 2015.
• The last three Current Deferred Tax Assets figures came in at $79.0 million (Q3 2015), $65.2 million (Q2 2015), and $57.0 million (Q1 2015), per Business Quant data.